Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™ [NA]
Feasibility study completed on a heparin-free hemodialysis approach using the Dialyzer With Endexo, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: The Iron and Muscle Study [Phase 4]
Phase 4 trial update on the Iron and Muscle Study evaluating CKD patients with iron deficiency.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism [Phase 3]
Phase 3 clinical trial assessing paricalcitol for secondary hyperparathyroidism in chronic kidney disease; status not specified.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia [Phase 2]
Phase 2 study of Roxadustat in non-dialysis chronic kidney disease patients with anemia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis [Phase 2]
Phase 2 trial investigating MT-9938 for uremic pruritus in end-stage renal disease patients on hemodialysis was terminated with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients [Phase 2]
Phase 2 trial evaluating the effect of enalapril, losartan, or no antihypertensive therapy on oxidative stress in renal transplant recipient…
-
CLINICAL_TRIALS trial_result · 2022-02-04Clinical Trial Update: Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients [Phase 4]
A Phase 4 clinical trial update evaluating short-term use of dapagliflozin to protect kidney function in chronic renal insufficiency patient…
-
CLINICAL_TRIALS trial_result · 2022-01-31Clinical Trial Update: A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart [Phase 1]
Phase 1 trial assessing the effect of verinurad on heart electrical activity in healthy volunteers, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Optimising Renal Outcome in Myeloma Renal Failure [Phase 2]
Phase 2 trial update on optimizing renal outcome in myeloma-related kidney failure.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment of Anemia in Hemodialysis Patients With Chronic Renal Failure [Phase 3]
Phase III clinical study investigating recombinant erythropoiesis-stimulating protein (rESP) for anemia in patients with chronic kidney dise…
-
CLINICAL_TRIALS trial_result · 2022-01-14Clinical Trial Update: Renal Actions of Combined Empagliflozin and LINagliptin in Type 2 diabetES [Phase 4]
Phase 4 trial update on the renal effects of combining empagliflozin and linagliptin in type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: CSP594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat [Phase 4]
A Phase 4 comparative effectiveness trial comparing allopurinol vs febuxostat in gout patients, including those with chronic kidney disease;…
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen [Phase 4]
Phase 4 clinical trial comparing steroid-free immunosuppression or calcineurin inhibitor minimization after basiliximab induction with a sta…
-
CLINICAL_TRIALS trial_result · 2021-12-03Clinical Trial Update: Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) [Phase 3]
Phase 3 trial update for daprodustat (a novel prolyl hydroxylase inhibitor) in anemia of chronic kidney disease (ASCEND-D) has completed wit…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet. [Phase 4]
Phase 4 clinical trial evaluating patiromer to facilitate transitioning chronic kidney disease patients with hyperkalemia to a plant-rich di…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Desidustat in the Treatment of Anemia in CKD [Phase 3]
Phase 3 trial update for desidustat in treating anemia associated with chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: Desidustat in the Treatment of Anemia in CKD on Dialysis Patients [Phase 3]
Phase 3 trial update for desidustat in treating anemia in chronic kidney disease patients on dialysis has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring Dialysis [Phase 2]
Phase 2 trial evaluating Roxadustat in anemia associated with chronic kidney disease not requiring dialysis has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: everlinQ endoAVF Post Market Study [NA]
Post-market study update for the everlinQ endoAVF in chronic kidney disease. The study was terminated and results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Viekira Pak or Mavyret Treatment for Patient With Chronic Kidney Disease and Hepatitis C [Phase 4]
Phase 4 trial updating outcomes of Viekira Pak or Mavyret in patients with chronic kidney disease and chronic hepatitis C; completed with re…
-
CLINICAL_TRIALS trial_result · 2021-11-05Clinical Trial Update: Rifaximin Therapy in Chronic Kidney Disease [Phase 4]
Phase 4 clinical trial update on rifaximin therapy in chronic kidney disease; study completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment [Phase 4]
A Phase 4 safety and efficacy trial of lesinurad 200 mg in participants with gout and renal impairment was terminated; results were posted i…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Metformin in Kidney Disease [Phase 2]
Phase 2 trial assessing metformin in chronic kidney disease with cardiovascular/metabolic syndrome comorbidity; completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-11-03Clinical Trial Update: Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ) [Phase 3]
Phase 3 study evaluating daprodustat (a prolyl hydroxylase inhibitor) for anemia in non-dialysis CKD patients; completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan. [Phase 2]
Phase 2 trial evaluating antibody-mediated IL-6 inhibition to reduce inflammation in patients with advanced chronic kidney disease has compl…